Trial Profile
Investigation of plasma remifentanil elimination rate and improvement of safety
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 11 Dec 2012 New trial record